Logo

Steven Kafka, Troy Cox, Konstantin Fiedler

Dec 20, 2017

Steven Kafka will resign as president and chief operating officer of Foundation Medicine, effective Feb. 16, 2018. CEO Troy Cox will take on the additional role of president, and Konstantin Fiedler will become COO. Fiedler joined the company in 2016 as senior vice president of international markets and managing director of FMI Germany, the firm's wholly-owned subsidiary in Germany. Prior to that, he was head of innovation of the healthcare unit of Linde, and before that, managing director in the Leica Biosystems division of Danaher. Earlier, he was a general manager in General Electric's life sciences division. Fiedler holds a master of science degree in physics from the University of Graz and a PhD in physics from the University of Konstanz.

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.